PYXIS DIAGNOSTICS

The human immune system can efficiently eradicate even widespread metastatic tumors, delivering durable survival benefit to cancer patients. Unfortunately, only a small subset of cancer patients benefit from immunotherapy; the rest lose valuable time and may suffer from diverse adverse events. Hence, biomarkers that predict a patient's response to immunotherapy are in urgent need... Leverage our ability to delineate the immune - tumor - stroma communication networks to identify patients that are likely to respond to immunotherapy and to discover new targets and drug combinations to treat those who do not.

Primary location: Jerusalem